Identification of new antiviral agents against Kaposi’s sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivationJungang Chen, Zhiqiang Qin|PLoS Pathogens|2019Cited by 33
Celecoxib Inhibits the Lytic Activation of Kaposi’s Sarcoma-Associated Herpesvirus through Down-Regulation of RTA Expression by Inhibiting the Activation of p38 MAPKJungang Chen, Xulin Chen|Viruses|2015Cited by 20